ENLV
Enlivex Therapeutics Ltd

7,288
Mkt Cap
$272.99M
Volume
341,198.00
52W High
$2.10
52W Low
$0.66
PE Ratio
-2.15
ENLV Fundamentals
Price
$1.16
Prev Close
$1.15
Open
$1.09
50D MA
$0.9793
Beta
0.64
Avg. Volume
478,581.90
EPS (Annual)
-$0.7319
P/B
1.60
Rev/Employee
$0.00
$0.9264
Loading...
Loading...

About

Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
36

Frequently Asked Questions

What is Market Cap of Enlivex Ltd.?
What is the 52-week high for Enlivex Ltd.?
What is the 52-week low for Enlivex Ltd.?
What is Enlivex Ltd. stock price today?
What was Enlivex Ltd. stock price yesterday?
What is the PE ratio of Enlivex Ltd.?
What is the Price-to-Book ratio of Enlivex Ltd.?
What is the 50-day moving average of Enlivex Ltd.?
How many employees does Enlivex Ltd. have?

Latest ENLV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.